GE Healthcare to launch a new biotech manufacturing facility in UK

| By | Cleanrooms, GE Healthcare, Pharmaceutical Plant Construction

GE Healthcare announced the opening of a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in Stevenage (UK).

In the first half of 2019, the center will start producing a fiber-based purification platform, which has the potential to significantly improve efficiency in the purification steps of manufacturing biopharmaceuticals, gene therapies and viral vectors.

The fiber-based purification platform comprises material with a unique proprietary structure. This has the potential to significantly improve process speed, flexibility and robustness during purification, a key step in the manufacturing of biopharmaceuticals. Additional products will also be produced at the center to serve both laboratory and clinical applications.

The new facility incorporates 280 square meters of cleanroom space. The fiber-based purification products will be prepared in Stevenage before being further processed and finished in GE Healthcare’s existing manufacturing facility in Cardiff (Wales, UK).

Biopharmaceuticals, such as monoclonal antibodies are the world’s fastest-growing class of medicines. The global market for biopharmaceuticals is estimated at more than $200 billion, and the market is growing around 8% annually. All the top 10 biologic drugs by global revenue use GE Healthcare technologies in their manufacture.

The purification technology came to GE Healthcare as part of the acquisition of Puridify, in November 2017. Puridify, founded at 2013, is a spin-out from University College London (UCL) and was based at the bio-incubator facility at the SBC, where GE Healthcare maintains an open laboratory aimed at providing SBC tenants with affordable access to advanced protein and cell analysis technologies.

GE Healthcare, the subsidiary of General Electric Corporation (GE), is a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, The company enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services.

SOURCE: ge healthcare
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.